Category Archives: Transfeminine

Put it under your tongue? Typical hormone levels for trans women on HRT, and differing effects of oral and parenteral estradiol

Posted on January 31, 2021 by Zinnia Jones

Previously: Many trans men on HRT may not show testosterone levels in the “target range” – and that can be okay (November 2020) Last year, I covered the results of a study of trans men and transmasculine people who had … Continue reading →

Posted in Endocrinology, Outcomes of transition, Transfeminine | Tagged , , , | Leave a comment

Three-year study examines trans women’s breast development from feminizing HRT

Posted on November 30, 2020 by Zinnia Jones

For trans women and transfeminine people who are considering or at the very beginning of feminizing hormone therapy, one of the most common points of concern – and uncertainty – is breast development. How soon will it start, how fast … Continue reading →

Posted in Breast, Endocrinology, Outcomes of transition, Progestogens, Transfeminine | Tagged , , | Leave a comment

Special considerations for breast augmentation in trans women

Posted on October 31, 2020 by Zinnia Jones

Note: This post contains illustrations of breast anatomy. Among trans women and transfeminine people, breast augmentation surgery is both frequently sought after and frequently received compared to the population of cis women. According to the 2015 U.S. Trans Survey, 8% … Continue reading →

Posted in Breast, Outcomes of transition, Surgery, Transfeminine | Tagged , | 3 Comments

Update on cases of lymphoma linked to textured breast implants in transgender women (BIA-ALCL)

Posted on September 30, 2020 by Zinnia Jones

I’ve previously covered emerging findings on breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL), a type of non-Hodgkin’s lymphoma caused by the textured surfaces of some implants used in breast augmentation surgeries. Textured surfaces have been used in some breast implants to … Continue reading →

Posted in Breast, Health care, Oncology, Surgery, Transfeminine | Tagged , | Leave a comment

Lower doses of cyproterone acetate may be similarly effective for blocking testosterone, with a lower risk of adverse effects

Posted on September 1, 2020 by Zinnia Jones

Previously: Cyproterone acetate and meningioma risk in trans women (March 2018) Update on case reports: Cyproterone acetate and meningioma in trans women (November 2018) Disclaimer: I am not a medical professional and this is not medical advice. Cyproterone acetate (CPA) … Continue reading →

Posted in Endocrinology, Oncology, Progestogens, Transfeminine, Transgender medicine | Tagged , , , | 1 Comment